| pubmed-article:11176958 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11176958 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:11176958 | lifeskim:mentions | umls-concept:C0030567 | lld:lifeskim |
| pubmed-article:11176958 | lifeskim:mentions | umls-concept:C0018524 | lld:lifeskim |
| pubmed-article:11176958 | lifeskim:mentions | umls-concept:C0042333 | lld:lifeskim |
| pubmed-article:11176958 | lifeskim:mentions | umls-concept:C0007328 | lld:lifeskim |
| pubmed-article:11176958 | lifeskim:mentions | umls-concept:C0936012 | lld:lifeskim |
| pubmed-article:11176958 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:11176958 | pubmed:dateCreated | 2001-2-22 | lld:pubmed |
| pubmed-article:11176958 | pubmed:abstractText | Visual hallucinations in Parkinson disease (PD) occur in approximately one third of patients treated long-term with dopaminergic medications. In Alzheimer disease, hallucinations and psychosis have been linked to increased representations of B2/B2 homozyogotes for the dopamine receptor gene DRD1 and 1/1 or 2/2 homozygotes for DRD3. In addition, a previous study of PD patients with and without hallucinations did not show differences in D2 and D3 polymorphisms, although careful case-control matching was not performed. Another study linked the apolipoprotein E4 (APOE4) allele to hallucinations in PD. | lld:pubmed |
| pubmed-article:11176958 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11176958 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11176958 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:11176958 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11176958 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11176958 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11176958 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:11176958 | pubmed:issn | 0003-9942 | lld:pubmed |
| pubmed-article:11176958 | pubmed:author | pubmed-author:GoetzC GCG | lld:pubmed |
| pubmed-article:11176958 | pubmed:author | pubmed-author:LeurgansSS | lld:pubmed |
| pubmed-article:11176958 | pubmed:author | pubmed-author:RamanRR | lld:pubmed |
| pubmed-article:11176958 | pubmed:author | pubmed-author:BurkeP FPF | lld:pubmed |
| pubmed-article:11176958 | pubmed:author | pubmed-author:ZhouLL | lld:pubmed |
| pubmed-article:11176958 | pubmed:author | pubmed-author:Berry-KravisE... | lld:pubmed |
| pubmed-article:11176958 | pubmed:author | pubmed-author:BlasucciL MLM | lld:pubmed |
| pubmed-article:11176958 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11176958 | pubmed:volume | 58 | lld:pubmed |
| pubmed-article:11176958 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11176958 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11176958 | pubmed:pagination | 209-13 | lld:pubmed |
| pubmed-article:11176958 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
| pubmed-article:11176958 | pubmed:meshHeading | pubmed-meshheading:11176958... | lld:pubmed |
| pubmed-article:11176958 | pubmed:meshHeading | pubmed-meshheading:11176958... | lld:pubmed |
| pubmed-article:11176958 | pubmed:meshHeading | pubmed-meshheading:11176958... | lld:pubmed |
| pubmed-article:11176958 | pubmed:meshHeading | pubmed-meshheading:11176958... | lld:pubmed |
| pubmed-article:11176958 | pubmed:meshHeading | pubmed-meshheading:11176958... | lld:pubmed |
| pubmed-article:11176958 | pubmed:meshHeading | pubmed-meshheading:11176958... | lld:pubmed |
| pubmed-article:11176958 | pubmed:meshHeading | pubmed-meshheading:11176958... | lld:pubmed |
| pubmed-article:11176958 | pubmed:meshHeading | pubmed-meshheading:11176958... | lld:pubmed |
| pubmed-article:11176958 | pubmed:meshHeading | pubmed-meshheading:11176958... | lld:pubmed |
| pubmed-article:11176958 | pubmed:meshHeading | pubmed-meshheading:11176958... | lld:pubmed |
| pubmed-article:11176958 | pubmed:meshHeading | pubmed-meshheading:11176958... | lld:pubmed |
| pubmed-article:11176958 | pubmed:meshHeading | pubmed-meshheading:11176958... | lld:pubmed |
| pubmed-article:11176958 | pubmed:meshHeading | pubmed-meshheading:11176958... | lld:pubmed |
| pubmed-article:11176958 | pubmed:meshHeading | pubmed-meshheading:11176958... | lld:pubmed |
| pubmed-article:11176958 | pubmed:meshHeading | pubmed-meshheading:11176958... | lld:pubmed |
| pubmed-article:11176958 | pubmed:meshHeading | pubmed-meshheading:11176958... | lld:pubmed |
| pubmed-article:11176958 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11176958 | pubmed:articleTitle | Genetic variation analysis in parkinson disease patients with and without hallucinations: case-control study. | lld:pubmed |
| pubmed-article:11176958 | pubmed:affiliation | Department of Neurological Sciences, Rush University/Rush-Presbyterian-St Luke's Medical Center, 1725 W Harrison St, Chicago, IL 60612, USA. | lld:pubmed |
| pubmed-article:11176958 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11176958 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| entrez-gene:348 | entrezgene:pubmed | pubmed-article:11176958 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:11176958 | lld:entrezgene |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11176958 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11176958 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11176958 | lld:pubmed |
